US Stock MarketDetailed Quotes

INSP Inspire Medical Systems

Watchlist
  • 187.770
  • +2.350+1.27%
Close Dec 20 16:00 ET
  • 186.000
  • -1.770-0.94%
Post 20:01 ET
5.63BMarket Cap169.16P/E (TTM)

Inspire Medical Systems Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
1,337.14%52.28M
-101.53%-78K
759.23%8.86M
113.10%24.65M
-10.39%17.27M
-66.93%3.64M
185.52%5.09M
89.46%-1.34M
157.50%11.57M
2,525.20%19.27M
Net income from continuing operations
316.59%18.5M
181.94%9.79M
35.13%-10.01M
52.87%-21.15M
368.67%14.76M
49.31%-8.54M
17.52%-11.95M
7.61%-15.42M
-6.75%-44.88M
231.74%3.15M
Depreciation and amortization
138.10%1.85M
109.86%1.38M
41.48%839K
53.18%2.85M
43.59%817K
51.46%777K
58.03%659K
65.18%593K
52.55%1.86M
65.41%569K
Other non cash items
-8.47%443K
-65.63%144K
46.20%519K
358.33%3.74M
603.12%2.48M
280.60%484K
26.59%419K
-11.25%355K
-40.35%816K
-9.72%353K
Change In working capital
161.06%5.68M
-540.87%-41.54M
2.71%-4.95M
-2,353.09%-40.78M
-10,052.00%-19.9M
-171.48%-9.3M
-33.07%-6.48M
22.07%-5.09M
126.40%1.81M
104.30%200K
-Change in receivables
-16.86%-9.9M
-67.54%-7.72M
1,173.47%18.96M
-11.85%-30.22M
-47.60%-18.63M
-3.47%-8.47M
20.94%-4.61M
489.79%1.49M
-192.27%-27.02M
-68.27%-12.62M
-Change in inventory
-59.42%-8.41M
-94.13%-10.05M
-299.50%-15.09M
-511.58%-22M
-338.45%-7.77M
-178.59%-5.27M
-1,613.74%-5.18M
23.96%-3.78M
161.07%5.35M
296.68%3.26M
-Change in prepaid assets
1,612.09%14.45M
-489.35%-18.93M
102.25%13K
-69.02%-4.76M
-64.19%-1.81M
311.71%844K
-50.59%-3.21M
-368.06%-579K
-304.45%-2.82M
-386.49%-1.1M
-Change in payables and accrued expense
165.02%9.54M
-174.42%-4.85M
-297.30%-8.84M
-38.42%16.19M
-22.11%8.31M
-74.81%3.6M
137.23%6.51M
-58.82%-2.23M
122.16%26.3M
158.95%10.67M
Cash from discontinued investing activities
Operating cash flow
1,337.14%52.28M
-101.53%-78K
759.23%8.86M
113.10%24.65M
-10.39%17.27M
-66.93%3.64M
185.52%5.09M
89.46%-1.34M
157.50%11.57M
2,525.20%19.27M
Investing cash flow
Cash flow from continuing investing activities
28.61%-102.97M
14.81%5.62M
-420.52%-19.54M
-1,404.50%-294.82M
-5,043.15%-151.72M
-3,734.16%-144.24M
142.87%4.9M
-156.18%-3.75M
-167.25%-19.6M
-453.47%-2.95M
Net PPE purchase and sale
-14.58%-8.01M
-155.26%-12.39M
-211.64%-11.7M
-159.77%-23.63M
-172.31%-8.03M
-98.97%-6.99M
-242.14%-4.86M
-208.89%-3.75M
-94.86%-9.1M
-453.47%-2.95M
Net investment purchase and sale
30.81%-94.96M
84.75%18.01M
---7.84M
-2,482.79%-271.19M
---143.69M
-54,801.20%-137.25M
197.50%9.75M
--0
-131.06%-10.5M
--0
Cash from discontinued investing activities
Investing cash flow
28.61%-102.97M
14.81%5.62M
-420.52%-19.54M
-1,404.50%-294.82M
-5,043.15%-151.72M
-3,734.16%-144.24M
142.87%4.9M
-156.18%-3.75M
-167.25%-19.6M
-453.47%-2.95M
Financing cash flow
Cash flow from continuing financing activities
182.57%9.89M
-52.54%7.09M
-86.36%768K
-94.07%13.95M
-238.77%-10.12M
-98.44%3.5M
2,312.60%14.93M
84.99%5.63M
1,472.63%235.08M
78.83%7.29M
Net issuance payments of debt
----
----
----
--0
----
----
----
----
---24.5M
--0
Net common stock issuance
----
----
----
--0
----
----
----
----
--243.8M
--0
Proceeds from stock option exercised by employees
254.21%14.23M
-43.73%8.95M
-50.98%3.62M
96.65%31.11M
-47.73%3.81M
128.05%4.02M
331.97%15.91M
138.97%7.38M
5.83%15.82M
78.83%7.29M
Net other financing activities
-740.12%-4.34M
-91.76%-1.86M
-63.12%-2.85M
-39,802.33%-17.16M
---13.93M
---516K
---971K
-3,960.47%-1.75M
---43K
--0
Cash from discontinued financing activities
Financing cash flow
182.57%9.89M
-52.54%7.09M
-86.36%768K
-94.07%13.95M
-238.77%-10.12M
-98.44%3.5M
2,312.60%14.93M
84.99%5.63M
1,472.63%235.08M
78.83%7.29M
Net cash flow
Beginning cash position
-59.74%188.04M
-60.32%175.42M
-57.98%185.54M
105.90%441.59M
-21.04%329.9M
150.34%467.05M
117.49%442.13M
105.90%441.59M
12.57%214.47M
98.77%417.81M
Current changes in cash
70.24%-40.8M
-49.32%12.63M
-1,955.24%-9.91M
-212.85%-256.22M
-712.38%-144.57M
-159.26%-137.1M
248.75%24.92M
104.78%534K
847.30%227.05M
451.98%23.61M
Effect of exchange rate changes
633.33%272K
-400.00%-10K
-3,666.67%-214K
118.67%164K
19.89%211K
59.84%-51K
-106.06%-2K
185.71%6K
494.74%75K
1,860.00%176K
End cash Position
-55.29%147.51M
-59.74%188.04M
-60.32%175.42M
-57.98%185.54M
-57.98%185.54M
-21.04%329.9M
150.34%467.05M
117.49%442.13M
105.90%441.59M
105.90%441.59M
Free cash flow
1,421.67%44.28M
-5,362.03%-12.47M
44.36%-2.84M
-58.59%1.02M
-43.42%9.23M
-144.73%-3.35M
103.21%237K
63.50%-5.1M
109.98%2.47M
8,018.91%16.32M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 1,337.14%52.28M-101.53%-78K759.23%8.86M113.10%24.65M-10.39%17.27M-66.93%3.64M185.52%5.09M89.46%-1.34M157.50%11.57M2,525.20%19.27M
Net income from continuing operations 316.59%18.5M181.94%9.79M35.13%-10.01M52.87%-21.15M368.67%14.76M49.31%-8.54M17.52%-11.95M7.61%-15.42M-6.75%-44.88M231.74%3.15M
Depreciation and amortization 138.10%1.85M109.86%1.38M41.48%839K53.18%2.85M43.59%817K51.46%777K58.03%659K65.18%593K52.55%1.86M65.41%569K
Other non cash items -8.47%443K-65.63%144K46.20%519K358.33%3.74M603.12%2.48M280.60%484K26.59%419K-11.25%355K-40.35%816K-9.72%353K
Change In working capital 161.06%5.68M-540.87%-41.54M2.71%-4.95M-2,353.09%-40.78M-10,052.00%-19.9M-171.48%-9.3M-33.07%-6.48M22.07%-5.09M126.40%1.81M104.30%200K
-Change in receivables -16.86%-9.9M-67.54%-7.72M1,173.47%18.96M-11.85%-30.22M-47.60%-18.63M-3.47%-8.47M20.94%-4.61M489.79%1.49M-192.27%-27.02M-68.27%-12.62M
-Change in inventory -59.42%-8.41M-94.13%-10.05M-299.50%-15.09M-511.58%-22M-338.45%-7.77M-178.59%-5.27M-1,613.74%-5.18M23.96%-3.78M161.07%5.35M296.68%3.26M
-Change in prepaid assets 1,612.09%14.45M-489.35%-18.93M102.25%13K-69.02%-4.76M-64.19%-1.81M311.71%844K-50.59%-3.21M-368.06%-579K-304.45%-2.82M-386.49%-1.1M
-Change in payables and accrued expense 165.02%9.54M-174.42%-4.85M-297.30%-8.84M-38.42%16.19M-22.11%8.31M-74.81%3.6M137.23%6.51M-58.82%-2.23M122.16%26.3M158.95%10.67M
Cash from discontinued investing activities
Operating cash flow 1,337.14%52.28M-101.53%-78K759.23%8.86M113.10%24.65M-10.39%17.27M-66.93%3.64M185.52%5.09M89.46%-1.34M157.50%11.57M2,525.20%19.27M
Investing cash flow
Cash flow from continuing investing activities 28.61%-102.97M14.81%5.62M-420.52%-19.54M-1,404.50%-294.82M-5,043.15%-151.72M-3,734.16%-144.24M142.87%4.9M-156.18%-3.75M-167.25%-19.6M-453.47%-2.95M
Net PPE purchase and sale -14.58%-8.01M-155.26%-12.39M-211.64%-11.7M-159.77%-23.63M-172.31%-8.03M-98.97%-6.99M-242.14%-4.86M-208.89%-3.75M-94.86%-9.1M-453.47%-2.95M
Net investment purchase and sale 30.81%-94.96M84.75%18.01M---7.84M-2,482.79%-271.19M---143.69M-54,801.20%-137.25M197.50%9.75M--0-131.06%-10.5M--0
Cash from discontinued investing activities
Investing cash flow 28.61%-102.97M14.81%5.62M-420.52%-19.54M-1,404.50%-294.82M-5,043.15%-151.72M-3,734.16%-144.24M142.87%4.9M-156.18%-3.75M-167.25%-19.6M-453.47%-2.95M
Financing cash flow
Cash flow from continuing financing activities 182.57%9.89M-52.54%7.09M-86.36%768K-94.07%13.95M-238.77%-10.12M-98.44%3.5M2,312.60%14.93M84.99%5.63M1,472.63%235.08M78.83%7.29M
Net issuance payments of debt --------------0-------------------24.5M--0
Net common stock issuance --------------0------------------243.8M--0
Proceeds from stock option exercised by employees 254.21%14.23M-43.73%8.95M-50.98%3.62M96.65%31.11M-47.73%3.81M128.05%4.02M331.97%15.91M138.97%7.38M5.83%15.82M78.83%7.29M
Net other financing activities -740.12%-4.34M-91.76%-1.86M-63.12%-2.85M-39,802.33%-17.16M---13.93M---516K---971K-3,960.47%-1.75M---43K--0
Cash from discontinued financing activities
Financing cash flow 182.57%9.89M-52.54%7.09M-86.36%768K-94.07%13.95M-238.77%-10.12M-98.44%3.5M2,312.60%14.93M84.99%5.63M1,472.63%235.08M78.83%7.29M
Net cash flow
Beginning cash position -59.74%188.04M-60.32%175.42M-57.98%185.54M105.90%441.59M-21.04%329.9M150.34%467.05M117.49%442.13M105.90%441.59M12.57%214.47M98.77%417.81M
Current changes in cash 70.24%-40.8M-49.32%12.63M-1,955.24%-9.91M-212.85%-256.22M-712.38%-144.57M-159.26%-137.1M248.75%24.92M104.78%534K847.30%227.05M451.98%23.61M
Effect of exchange rate changes 633.33%272K-400.00%-10K-3,666.67%-214K118.67%164K19.89%211K59.84%-51K-106.06%-2K185.71%6K494.74%75K1,860.00%176K
End cash Position -55.29%147.51M-59.74%188.04M-60.32%175.42M-57.98%185.54M-57.98%185.54M-21.04%329.9M150.34%467.05M117.49%442.13M105.90%441.59M105.90%441.59M
Free cash flow 1,421.67%44.28M-5,362.03%-12.47M44.36%-2.84M-58.59%1.02M-43.42%9.23M-144.73%-3.35M103.21%237K63.50%-5.1M109.98%2.47M8,018.91%16.32M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
NVIDIA
NVDA
+3.08%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%
Alphabet-C
GOOG
+1.72%

Unlock the Full List